Ironwood Pharmaceuticals and Bionomics announce collaboration research
Companies to Collaborate on Central Nervous System Disorder Opportunity
06-Jan-2012 -
Ironwood Pharmaceuticals, Inc. and Bionomics Limited announced that they entered into a collaboration, research, and licensing agreement that will enable Ironwood to develop and commercialize Bionomics’ investigational anti‐anxiety compound BNC210 and other related compounds. The goal of the ...
anxiety
drug development